This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PRDM16 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PRDM16 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~140.3 kDa | |
| Gel | 8–10% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 4 isoform(s) |
The A00782 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Target-positive lysate and matched negative control (standard starting point) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A00782; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | 1 h (catalog A00782) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PRDM16 is predicted at 140.3 kDa; four isoforms could affect migration, but no empirical band position or distinct isoform bands are established.
| Band near 140.3 kDa | Consistent with the predicted PRDM16 mass; identity requires confirmation |
| Several bands at different positions | Could reflect PRDM16 isoforms 1, 2, 3, and 4 if they migrate differently |
| One band despite four annotated isoforms | The isoforms may not resolve or may not all be detected |
| Weak or absent band in whole-cell lysate | PRDM16 is found in the nucleus, on chromosomes, and in the cytoplasm |
| Predicted PRDM16 mass | Provides a 140.3 kDa sequence-based reference, not a measured band position |
| Isoform 1 | Its individual mass and migration are not supplied |
| Isoform 2 | May differ in size from other isoforms; its mass is not supplied |
| Isoform 3 | May differ in size from other isoforms; its mass is not supplied |
| Isoform 4 | May differ in size from other isoforms; its mass is not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear or chromosome-associated PRDM16 may be poorly recovered | Check nuclear extraction and use a positive control |
| Band higher than expected | The reason for migration above 140.3 kDa is not established | Check marker calibration and confirm identity by knockdown or a second antibody |
| Band lower than expected | An alternative isoform is possible, but its mass is unknown | Check antibody epitope coverage and confirm identity by knockdown |
| Multiple bands | Four annotated isoforms could contribute if expressed and resolved | Compare isoform expression and use knockdown to identify PRDM16 bands |
| Weak or no signal | PRDM16 distribution between nucleus and cytoplasm may affect recovery | Compare nuclear and cytoplasmic fractions with loading controls |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for PRDM16, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports A00782, an anti-PRDM16 antibody with reported Human, Mouse, and Rat reactivity. Its Western blot image uses 15 μg of MCF7 cell lysate; the supplied evidence does not show Western blot results for other specimens.
Which to pick: A00782 is the only listed option. Choose it if its reported reactivity fits your sample; its supplied Western blot image documents MCF7 cells under the stated conditions, so performance in other samples remains unshown here.